Abstract
The rabbit was the initial animal model to investigate the acetylation polymorphism expressed in humans. Use of the rabbit model is compromised by lack of a rapid non-invasive method for determining acetylator phenotype. Slow acetylator phenotype in the rabbit results from deletion of the N-acetyltransferase 2 (NAT2) gene. A relatively quick and non-invasive method for identifying the gene deletion was developed and acetylator phenotypes confirmed by measurement of N- and O-acetyltransferase activities in hepatic cytosols. Rabbit liver cytosols catalyzed the N-acetylation of sulfamethazine (p = 0.0014), benzidine (p = 0.0257), 4-aminobiphenyl (p = 0.0012), and the O-acetylation of N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N–OH–PhIP; p = 0.002) at rates significantly higher in rabbits possessing NAT2 gene than rabbits with NAT2 gene deleted. In contrast, hepatic cytosols catalyzed the N-acetylation of p-aminobenzoic acid (an N-acetyltransferase 1 selective substrate) at rates that did not differ significantly (p > 0.05) between rabbits positive and negative for NAT2. The new NAT2 genotyping method facilitates use of the rabbit model to investigate the role of acetylator polymorphism in the metabolism of aromatic and heterocyclic amine drugs and carcinogens.
This is a preview of subscription content, log in via an institution to check access.
References
Blum M, Grant DM, Demierre A, Meyer UA (1989) N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits. Proc Natl Acad Sci USA 86(23):9554–9557
Blum M, Heim M, Meyer UA (1990) Nucleotide sequence of rabbit NAT2 encoding polymorphic liver arylamine N-acetyltransferase (NAT). Nucleic Acids Res 18(17):5295
Fretland AJ, Devanaboyina US, Doll MA, Zhao S, Xiao GH, Hein DW (2003) Metabolic activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian hamsters congenic at the N-acetyltransferase 2 (NAT2) locus. Toxicol Sci 74(2):253–259
Glowinski IB, Weber WW, Fysh JM, Vaught JB, King CM (1980) Evidence that arylhydroxamic acid N, O-acyltransferase and the genetically polymorphic N-acetyltransferase are properties of the same enzyme in rabbit liver. J Biol Chem 255(16):7883–7890
Hein DW, Smolen TN, Fox RR, Weber WW (1982) Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains. J Pharmacol Exp Ther 223(1):40–44
Hein DW, Doll MA, Nerland DE, Fretland AJ (2006) Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster. Mol Carcinog 45(4):230–238
Sasaki Y, Ohsako S, Deguchi T (1991) Molecular and genetic analyses of arylamine N-acetyltransferase polymorphism of rabbit liver. J Biol Chem 266(20):13243–13250
Vatsis KP, Weber WW, Bell DA et al (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics 5(1):1–17
Weber WW, Hein DW (1985) N-acetylation pharmacogenetics. Pharmacol Rev 37(1):25–79
Zenser TV, Lakshmi VM, Rustan TD et al (1996) Human N-acetylation of benzidine: role of NAT1 and NAT2. Cancer Res 56(17):3941–3947
Acknowledgements
Funding was provided by National Institute of General Medical Sciences (Grant No. P20-GM113226).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hein, D.W., Doll, M.A. Rabbit N-acetyltransferase 2 genotyping method to investigate role of acetylation polymorphism on N- and O-acetylation of aromatic and heterocyclic amine carcinogens. Arch Toxicol 91, 3185–3188 (2017). https://doi.org/10.1007/s00204-017-1997-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-017-1997-7